Danish Registry Study of 756,636 Pregnancies Ties Higher Preterm Birth Risk After Early GLP-1 Exposure to Diabetes, Not Weight-Loss Use
Copenhagen researchers identified 529 pregnancies in which the mother filled a liraglutide or semaglutide prescription within eight weeks before or after the start of her last menstrual period. Among women using the drugs for diabetes, the adjusted odds of preterm birth were 1.70 times higher with liraglutide and 1.84 times higher with semaglutide than in matched unexposed pregnancies; among women using them for weight management, there was no association. The study, published in Human Reproduction Open in March and publicized by the European Society of Human Reproduction and Embryology on November 13, cannot establish cause.